NZ505834A - Compositions containing polypeptides isolated from mycobacterium vaccae and methods for their use - Google Patents

Compositions containing polypeptides isolated from mycobacterium vaccae and methods for their use

Info

Publication number
NZ505834A
NZ505834A NZ505834A NZ50583498A NZ505834A NZ 505834 A NZ505834 A NZ 505834A NZ 505834 A NZ505834 A NZ 505834A NZ 50583498 A NZ50583498 A NZ 50583498A NZ 505834 A NZ505834 A NZ 505834A
Authority
NZ
New Zealand
Prior art keywords
methods
vaccae
compositions containing
delipidated
containing polypeptides
Prior art date
Application number
NZ505834A
Other languages
English (en)
Inventor
Elizabeth S Visser
Margot A Skinner
Ross L Prestidge
Paul Tan
James Watson
Linda M Scott
Original Assignee
Genesis Res & Dev Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/997,362 external-priority patent/US5985287A/en
Priority claimed from US08/997,080 external-priority patent/US5968524A/en
Priority claimed from US09/095,855 external-priority patent/US6160093A/en
Priority claimed from US09/205,426 external-priority patent/US6406704B1/en
Application filed by Genesis Res & Dev Corp Ltd filed Critical Genesis Res & Dev Corp Ltd
Publication of NZ505834A publication Critical patent/NZ505834A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NZ505834A 1997-12-23 1998-12-23 Compositions containing polypeptides isolated from mycobacterium vaccae and methods for their use NZ505834A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US99662497A 1997-12-23 1997-12-23
US08/997,362 US5985287A (en) 1996-08-29 1997-12-23 Compounds and methods for treatment and diagnosis of mycobacterial infections
US08/997,080 US5968524A (en) 1997-12-23 1997-12-23 Methods and compounds for the treatment of immunologically-mediated psoriasis
US09/095,855 US6160093A (en) 1996-08-29 1998-06-11 Compounds and methods for treatment and diagnosis of mycobacterial infections
US15618198A 1998-09-17 1998-09-17
US09/205,426 US6406704B1 (en) 1996-08-29 1998-12-04 Compounds and methods for treatment and diagnosis of mycobacterial infections
PCT/NZ1998/000189 WO1999032634A2 (en) 1997-12-23 1998-12-23 Compositions derived from mycobacterium vaccae and methods for their use

Publications (1)

Publication Number Publication Date
NZ505834A true NZ505834A (en) 2002-12-20

Family

ID=27557521

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ505834A NZ505834A (en) 1997-12-23 1998-12-23 Compositions containing polypeptides isolated from mycobacterium vaccae and methods for their use

Country Status (15)

Country Link
EP (1) EP1044273A2 (xx)
JP (1) JP2002514385A (xx)
CN (1) CN1294632A (xx)
AU (1) AU746311B2 (xx)
BR (1) BR9814432A (xx)
CA (1) CA2315539A1 (xx)
HU (1) HUP0100352A2 (xx)
ID (1) ID26327A (xx)
IL (1) IL136821A0 (xx)
MX (1) MXPA00006168A (xx)
NO (1) NO20003261L (xx)
NZ (1) NZ505834A (xx)
PL (1) PL341697A1 (xx)
TR (1) TR200001948T2 (xx)
WO (1) WO1999032634A2 (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6569436B1 (en) 1998-10-05 2003-05-27 The Malaghan Institute Of Medical Research Method of using a vaccine
JP4415200B2 (ja) * 1999-01-29 2010-02-17 大塚製薬株式会社 遅発育性抗酸菌ポリペプチド
GB9903539D0 (en) * 1999-02-16 1999-04-07 Stanford Rook Ltd Therapy using M.Vaccae
US6350457B1 (en) * 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
MXPA01013097A (es) * 1999-07-12 2002-06-04 Genesis Res & Dev Corp Ltd Compuestos para el tratamiento del sistema infeccioso e inmune y metodos para su uso..
US7217554B2 (en) 1999-08-31 2007-05-15 Novozymes A/S Proteases and variants thereof
EP2336331A1 (en) * 1999-08-31 2011-06-22 Novozymes A/S Novel proteases and variants thereof
CA2381139A1 (en) * 1999-08-31 2001-03-08 Michael Niederweis Method for the production of a channel forming protein
US6361776B1 (en) * 1999-12-06 2002-03-26 Genesis Research & Development Corp. Ltd. Compounds isolated from M. vaccae and their use in modulation of immune responses
US20030108527A1 (en) * 1999-12-28 2003-06-12 Tsukasa Seya Maturation-promoting agent for immature dendrtic cells
AUPQ761200A0 (en) * 2000-05-19 2000-06-15 Hunter Immunology Limited Compositions and methods for treatment of mucosal infections
US20030104012A1 (en) * 2001-05-11 2003-06-05 Corixa Corporation Vaccines for the treatment of autoimmune disease
US20030147861A1 (en) * 2001-07-26 2003-08-07 Genesis Research And Development Corporation Limited Compounds and methods for the modulation of immune responses
WO2003049751A1 (en) * 2001-12-10 2003-06-19 Bakulesh Mafatlal Khamar The process of manufacturing a pharmaceutical composition useful for management of cancer
GB0303507D0 (en) * 2003-02-14 2003-03-19 Novartis Ag Organic compounds
WO2015104380A1 (en) * 2014-01-09 2015-07-16 Transgene Sa Fusion of heterooligomeric mycobacterial antigens

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions
GB9203814D0 (en) * 1992-02-21 1992-04-08 Univ London Treatment of long term auto-immune conditions
US6284255B1 (en) * 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections

Also Published As

Publication number Publication date
HUP0100352A2 (hu) 2001-06-28
JP2002514385A (ja) 2002-05-21
TR200001948T2 (tr) 2001-02-21
WO1999032634A2 (en) 1999-07-01
BR9814432A (pt) 2000-10-10
CN1294632A (zh) 2001-05-09
AU1893699A (en) 1999-07-12
AU746311B2 (en) 2002-04-18
ID26327A (id) 2000-12-14
MXPA00006168A (es) 2005-02-24
EP1044273A2 (en) 2000-10-18
CA2315539A1 (en) 1999-07-01
NO20003261L (no) 2000-08-22
NO20003261D0 (no) 2000-06-22
WO1999032634A3 (en) 1999-12-02
IL136821A0 (en) 2001-06-14
PL341697A1 (en) 2001-04-23

Similar Documents

Publication Publication Date Title
NZ505834A (en) Compositions containing polypeptides isolated from mycobacterium vaccae and methods for their use
NZ333607A (en) Method of stimulating the immune system by transfecting dendritic cells
ATE314095T1 (de) Virusähnliche partikel zur induktion von autoantikörpern
WO1998055495A3 (en) Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
IL141775A0 (en) Aglyco products and methods of use
WO1998008542A3 (en) Compounds and methods for treatment and diagnosis of mycobacterial infections
HK1142093A1 (en) Process for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process
HK1086750A1 (en) Pharmaceutical composition for inducing an immune response in a human or animal
PL332694A1 (en) Purine l-nucleosides, their analoques and their application
CA2033640A1 (en) Vaccines against cancer and infectious diseases
PL336580A1 (en) Fine-molecular compounds useful in treating inflammatory diseases
ATE389712T1 (de) Krebs immuntherapie mit semi-allogenen zellen
IL138424A0 (en) Covalently reactive antigen analogs and pharmaceutical compositions containing the same
WO1999003976A3 (en) Method of treating leukocytes, leukocyte compositions and methods of use thereof
WO1998039034A3 (de) Verwendung von anti-cd44 antikörper enthaltenden präparationen zur behandlung bestimmter tumore und zur unterdrückung von immunreaktionen
CA2232344A1 (en) Compositions and methods for enhancing immune responses mediated by antigen-presenting cells
GB2355983A (en) Method for producing or enhancing a T-cell response against a target cell using a complex comprising an HLA class 1 molecule and an attaching means
CA2064029A1 (en) Use of mycobacterium vaccae in the prevention of aids
EP0202642A3 (en) Process for the in vitro immunization of human splenocytes against tumor associated antigens
WO1999049876A3 (en) Bacterial or yeast extracts which stimulate the production of defensins and methods of use thereof
WO2001059073A3 (en) Cytotoxic t lymphocytes activated by dendritic cell hybrids
WO2000052045A3 (en) Mage-3 derived immunogenic peptides presented by mhc of class ii and the use thereof
AU3929589A (en) Human papilloma virus type 57, the dna thereof and the proteins encoded thereby
AU617330B2 (en) Human papillomavirus type 41, its DNA and the proteins encoded therefrom
WO2000077177A3 (en) Isolation of a human retrovirus

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
PSEA Patent sealed